In the last trading session, 1.26 million shares of the Atyr Pharma Inc (NASDAQ:ATYR) were traded, and its beta was 0.87. Most recently the company’s share price was $3.49, and it changed around -$0.21 or -5.68% from the last close, which brings the market valuation of the company to $310.12M. ATYR currently trades at a discount to its 52-week high of $4.66, offering almost -33.52% off that amount. The share price’s 52-week low was $1.42, which indicates that the current value has risen by an impressive 59.31% since then. We note from Atyr Pharma Inc’s average daily trading volume that its 10-day average is 1.54 million shares, with the 3-month average coming to 1.28 million.
Atyr Pharma Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 11 analysts rate the stock as a Sell; another 4 rate it as Overweight. Among the rest, 0 recommended ATYR as a Hold, whereas 7 deemed it a Buy, and 0 rated it as Underweight. Atyr Pharma Inc is expected to report earnings per share of -0.19 for the current quarter.
Atyr Pharma Inc (NASDAQ:ATYR) trade information
Instantly ATYR has showed a red trend with a performance of -5.68% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 3.98 on recent trading dayincreased the stock’s daily price by 12.31%. The company’s shares are currently down -3.59% year-to-date, but still down -9.82% over the last five days. On the other hand, Atyr Pharma Inc (NASDAQ:ATYR) is -8.88% down in the 30-day period. We can see from the shorts that 6.92 million shares have been sold at a short interest cover period of 3.39 day(s).
Atyr Pharma Inc (ATYR) estimates and forecasts
The year-over-year growth rate is expected to be 751.06%, up from the previous year.
Analysts predict that the company’s current quarter sales will drop, forecast at -100.00%. Forecasts for the next quarter put sales growth at 0.00%.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 34.28%.
ATYR Dividends
Atyr Pharma Inc’s next quarterly earnings report is expected to be released on 2025-Mar-12.
Atyr Pharma Inc (NASDAQ:ATYR)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 2.24% of Atyr Pharma Inc shares, and 61.91% of them are in the hands of institutional investors. The stock currently has a share float of 63.33%.
Federated Hermes Kaufmann Fund and Federated Hermes Kaufmann Small Cap Fund were the top two Mutual Funds as of Oct 31, 2024 . The former held 7.85 shares worth $27.4 million, making up 8.83% of all outstanding shares. On the other hand, Federated Hermes Kaufmann Small Cap Fund held roughly 6.62 shares worth around $23.1 million, which represents about 7.45% of the total shares outstanding.
